Drug Type Small molecule drug |
Synonyms EM4615 |
Target |
Action inhibitors |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC40H74O14S3 |
InChIKeyZIKVIJYTFFPQEA-UHFFFAOYSA-N |
CAS Registry76265-39-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bacterial Infections | Preclinical | United States | 01 Nov 1980 |





